Haemotopoietic stem cell transplantation for thalassaemia major in Hong Kong: Prognostic factors and outcome

Bone Marrow Transplantation

Volumn 29, Issue 2, 2002, Pages 101-105

  Li, C K ^a   Shing, M M K ^a   Chik, K W ^a   Lee, V ^a   Leung, T F ^a   Cheung, A Y K ^a   Yuen, M P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Prognostic factor; Thalassaemia; Transplant

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DONOR; FATHER; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAZARD ASSESSMENT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HONG KONG; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LIVER BIOPSY; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SIBLING; SURVIVAL RATE; THALASSEMIA MINOR; UMBILICAL CORD BLOOD; AGE; BETA THALASSEMIA; HISTOCOMPATIBILITY TEST; HOMOZYGOTE; INFANT; LIVER VEIN OBSTRUCTION; PRESCHOOL CHILD; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HISTOCOMPATIBILITY TESTING; HOMOZYGOTE; HONG KONG; HUMANS; INFANT; MALE; PROGNOSIS; RISK FACTORS; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036007877     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703340     Document Type: Article

References (22)

1. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong - Implications for population screening
2. Survival in β-thalassaemia major in the UK: Data from the UK Thalassaemia Register
3. Bone marrow transplantation in thalassemia. The experience of Pesaro
4. Bone marrow transplantation for thalassemia the USA experience
5. BMT for children with β-thalassemia major in the UK
6. Allogeneic bone marrow transplantation for thalassemia in Taiwan: Factors associated with graft failure
7. Bone marrow transplantation in patients with thalassemia
8. Early iron reduction programme for thalassaemia patients after bone marrow transplantation
9. The β-thalassemias
10. Transfusion-related immuno-modulation in Chinese children with thalassaemia
11. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy
12. Bone marrow transplantation in adult thalassemic patients
13. Hepatic iron concentration and total body iron stores in thalassemia major
14. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics
15. Busulphan level and early mortality in thalassaemia patients after BMT
16. Marrow transplantation for patients with thalassemia: Results in class 3 patients
17. Engraftment failure following bone marrow transplantation in children with thalassemia major using busulfan and cyclophosphamide conditioning
18. Clinical efficacy of five filters specific for leukocyte removal
19. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia
20. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation
21. Disparate lympho-erythroid donor to recipient chimaerism in a beta degrees-thalassaemia bone marrow transplant recipient with red cell indices indicative of apparent full engraftment
22. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for β-thalassemia major